The National Pharmaceutical Council’s Vice President of Comparative Effectiveness Research Jennifer Graff says payers use a wide swath of information to make coverage and reimbursement decisions.
Graff said in an interview with the American Journal of Managed Care that the best evidence could include “FDA information, manufacturer supported information, clinical trials, real-world evidence and cost-effectiveness.”
“We know this by peeling back the onion to try to understand not only what payers say the do and utilize, but also looking at P&T monographs or looking at medical coverage policies to understand what types of evidence they cite,” Graff said. “It’s a wide variety of types of information and often very disparate.”
